Prognostic Factors and Outcome of Patients with Adult Acute Lymphoblastic Leukemia Treated with the Hyper-CVAD Regimen: A Retrospective Study

AIM: The Hyper-CVAD regimen has shown promising results for adult patients with acute lymphoblastic leukemia (ALL), as designed by the MD Anderson Cancer Center (MDACC). This treatment has resulted in a complete remission rate of 92% and a 5-year overall survival of 38%. However, given the diversity...

Descripción completa

Detalles Bibliográficos
Autores principales: Malakoutikhah, Zahra, Ashrafi, Farzaneh, Derakhshandeh, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653974/
https://www.ncbi.nlm.nih.gov/pubmed/38029004
http://dx.doi.org/10.1155/2023/5593635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653974/
https://www.ncbi.nlm.nih.gov/pubmed/38029004
http://dx.doi.org/10.1155/2023/5593635

Ejemplares similares